Ivy extract vs NAC for COPD: Which works better?
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares two treatments – a dry powder ivy extract and a common mucus-thinning medicine called NAC – to see which is safer and more effective for people with stable COPD. If you have COPD and are over 40, this trial could help find a better option to manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD that stays stable (not a sudden worsening)
- You are 40 years old or older
- You can perform a breathing test called spirometry
- You do not have asthma, lung cancer, or other chronic lung diseases
- You have not been taking mucolytics (medicines that thin mucus) regularly for at least a month
- You are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an inhaled medicine (GDC-6988) to see if it is safe and helps clear mucus from the lungs in people with mucus-related lung diseases like chronic bronchitis, COPD, or bronchiectasis. You may qualify if your lung function is fairly stable and you produce daily mucus.
This trial tests whether a medication called N-acetylcysteine (also known as NAC) helps clear mucus from the lungs faster in people with bronchiectasis who are hospitalized for a sudden worsening of symptoms. The goal is to see if it improves breathing and speeds up recovery.
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
This study tests whether vitamin C, an antioxidant, can help slow the progression of COPD and improve prognosis. If you qualify, you may take vitamin C and have your lung health monitored over time.
This study compares two types of breathing support for people having a severe COPD flare-up with high carbon dioxide and acidic blood. It tests if a gentle air flow through the nose (nasal high flow) works as well as a mask (non-invasive ventilation) to help you breathe better.
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.